key: cord-0920430-aj4vhmc4
authors: Brest, Patrick; Mograbi, Baharia; Hofman, Paul; Milano, Gerard
title: Using Genetics to dissect out SARS-Cov-2 infection
date: 2020-11-26
journal: Trends Genet
DOI: 10.1016/j.tig.2020.11.007
sha: 9f0b462a73983a528fa5e32e4e1ab21ba8032956
doc_id: 920430
cord_uid: aj4vhmc4

To uncover the host key-cellular pathways associated with SARS-CoV-2 infectiousness, Daniloski and coworkers have used CRISPR-based whole genome screening. Their results could lead to propose new or repositioned drugs for the continuous fight against COVID-19.

associated with this emerging infectious disease. Major advances in SARS-CoV-2 pathogenesis, hostvirus mechanisms of interaction, immunological and genetic implications constitute a major scientific interplay with COVID-19. Genetic studies linked to the COVID-19 pandemic have recently uncovered new knowledge based on large GWAS studies revealing a multiple gene locus at 3p 34.2 and ABO blood group locus at 9q 34.2 which points towards a large set of complementary predisposing factors to severe COVID-19 [2] . As a complement to such a global strategy, we recently raised the hypothesis that germinal polymorphisms (SNPs) may regulate the expression of SARS-CoV-2 cellular target itself (ACE2) and the two main proteases regulating its cell membrane processing [3] . This was based on a broad public database compilation and allowed us to define complementary risk factors for developing COVID-19 [3] .

Genetics, was also the basis of a study recently published in Cell en titled "Identification of required host factors for SARS-Cov-2 infection in human cells" [4] . The purpose of this work was to contribute to the identification of new potential therapeutic targets for the virus, based on genome-scale, loosof function CRISPR screens in order to systematically knockout components of the human genome [4] . The investigators specifically utilized human lung cells resistant to SARS-CoV-2 infection. This led them to discover that the top-ranked genes, whose loss significantly reduces viral infection, clustered into protein complexes including vacuolar ATPases, Retromer, Commander, Arp2/3 and PI3K.

Researchers applied different molecular strategies in order to validate their findings. Among them, they used knockout by CRISPR, gene suppression using RNAi or drug inhibition. A particular focus on ACE2 resulted from the main results with the identification of one gene, RAB7A which had a marked influence on ACE2 trafficking to the cell membrane, likely by sequestering ACE2 in endosomal vesicles. Interestingly, the influence of cholesterol biosynthesis pathway as a negative regulator of SARS-CoV-2 was also reported. In our opinion, the main genome-scale loss-of-function discovery was the involvement of PI3K pathway that was furthermore confirmed by the majority of PI3KC3 inhibitors resulting in more than 100-fold reduction of SARS-CoV-2 viral load. Interestingly, J o u r n a l P r e -p r o o f Journal Pre-proof Tamoxifen, a well-known and used anticancer drug modulating the estrogen receptor, showed a substantial reduction in SARS-CoV-2 viral load.

Since the discovery of the CRISPR-CAS9 system by Emmanuelle Charpentier and Jennifer Doudna, awarded the Nobel prize in 2020, this system has been applied to a wide range of situations. Indeed, if compared with RNAi technology, the gene-silencing efficiency of the CRISPR system performs better and the target genes can be completely deleted. Genome-wide loss-of-function screens have nowadays been acknowledged to uncover host dependency factors for virus infection, including Human Immunodeficiency Virus, West Nile virus, dengue virus , and Zika virus [5, 6] . There are currently 4 studies that have used CRISPR screening to investigate genes important for SARS-CoV-2 infection [4, [7] [8] [9] . Among these studies, which have used only two cell types VERO-TMPRSS2 and A549-ACE2, it is puzzling to find so little overlap of genes important for SARS-CoV-2 infectiousness, apart from ACE2 itself. Intriguingly, the levels of ACE2 have been evaluated either by cytometry or by mRNA quantification rendering the comparison difficult between the models. Furthermore, the apparent lack of reproducibility may raise some concerns about some technical issues (such as different CRISPR libraries or variations in guide representation) or biological differences (such as different cell types, different host species, cell culture heterogeneity, confluency or even serum conditions) [4, [7] [8] [9] .

All these points highlight the urgent need of reproducibility for experiments between laboratories for validation but also the need for different cellular models [10] or recently consensual animal models (Figure 1 ). In this context, two approaches could be envisaged, one based on new CRISPR system (CRISPRa/i) that would target promoter activity not only for coding genes but also for non-coding genes, identifying even more accurately the possible regulators of SARS-Cov-2 load and 

Authors declare no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. 

Covid-19 -Implications for the Health Care System

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

Host Polymorphisms May Impact SARS-CoV-2 Infectivity

Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells

A CRISPR screen defines a signal peptide processing pathway required by flaviviruses

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

The S1/S2 boundary of SARS-CoV-2 spike protein modulates cell entry pathways and transmission

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2. bioRxiv